GrowthWorks Capital is a Vancouver-based venture capital firm focused on the management of regionally-based venture capital funds.
Business Model:
Revenue: $9.9M
Employees: 2-10
Address: Box 11170, Royal Centre 2600
City: Vancouver
State: british columbia
Zip: V6E 3R5
Country: CA
Invest in our experience GrowthWorks* offers you more: more accountability, more experience and more proven know-how to make the most of your investment. A principled approach to adding value Over the last 20 years, we&s;ve built GrowthWorks into one of Canada&s;s venture capital management companies. We&s;ve done that by managing funds that rigorously follow core principles: structure strategic investments in growth-oriented companies, value portfolio assets conservatively, build vital industry connections and minimize risk through diversification. It&s;s a simple formula that delivers powerful results. Regional know-how. National Reach At GrowthWorks, we offer regionally based retail venture capital funds (RVCs) right across Canada. GrowthWorks specializes in the management of and growth of regionally based venture capital funds. The funds under management include the following RVCs: Working Opportunity Fund, GrowthWorks Commercialization Fund and GrowthWorks Atlantic Venture Fund. Partners in performance We have specialized teams in each of our core sectors to identify and structure investments in potential winners. These skilled teams also help create success by helping the companies that GrowthWorks managed funds invest in to grow with strategic management support and advice. This way, the companies get guidance from experienced leaders. In turn, the funds’ investors know that these companies receive direction to help them thrive.
Contact Phone:
+18002688244
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
4/2008 | Strutta | Seed Round | 0 |
1/2008 | Azorus | Venture Round | - |
10/2009 | Strutta | Debt Financing | 383.3k |
3/2001 | Neuromed Pharmaceuticals | Series B | 21M |
2/2012 | GenoLogics | Series D | 8M |
6/2008 | iMPath Networks | Venture Round | 3M |
9/2011 | gShift | Series A | 1.6M |
1/2007 | Sofea | Venture Round | 5.3M |
11/2007 | xkoto | Series B | 7.5M |
7/2010 | Copperleaf Technologies | Series A | 483.7k |
1/2012 | Spinzo | Seed Round | 592.2k |
11/2012 | Ambit Biosciences | Venture Round | 0 |
2/2010 | Vitrium Systems Inc. | Venture Round | - |
2/2007 | Trigence | Series B | 8M |
4/2001 | Xenon Pharmaceuticals | Venture Round | 45M |
4/2009 | Teradici | Series C | 0 |
6/2008 | Inimex Pharmaceuticals | Series B | 22M |
10/2006 | Layer 7 Technologies | Series B | 0 |
1/2004 | Atsana Semiconductor | Venture Round | 10M |
10/2005 | AnyWare Group | Series B | 3.7M |
6/2011 | Ambit Biosciences | Series D | 0 |
9/2000 | Cogency Semiconductor | Series B | 20M |
7/2008 | Cytochroma | Series C | 0 |
2/2007 | Sirific Wireless | Series C | 0 |
10/2008 | Librestream Technologies | Venture Round | 8.6M |
7/2007 | Brownbag | Series A | 10.6M |
7/2007 | NowPublic | Series A | 10.6M |
5/2006 | D-Wave Systems | Series B | 14M |
12/2007 | Zeugma Systems | Series B | 20M |
1/2007 | PlanetEye | Series A | - |
4/2000 | SiberCore Technologies | Series B | 8.5M |
12/2008 | Sysomos | Seed Round | 250k |
1/2006 | QuIC Financial Technologies | Series B | 10M |
9/2010 | Celator Pharmaceuticals | Series D | 0 |
8/2003 | Datawire Communication Networks | Series B | 0 |
12/2004 | Teradici | Venture Round | 10M |
6/2001 | NxtPhase | Venture Round | 25M |
8/2007 | Kibboko, Inc. | Series B | 2.5M |
9/2011 | MSI Methylation Sciences | Series A | 18.4M |
7/2008 | Celator Pharmaceuticals | Series C | 22.5M |
7/2004 | Inimex Pharmaceuticals | Series A | 4.5M |
2/2006 | Objectworld Communications | Series B | 6.5M |
1/2008 | D-Wave Systems | Series C | 0 |
2/2002 | Colligo | Seed Round | 3.5M |
10/2006 | GenoLogics | Series B | - |
3/2006 | Neuromed Pharmaceuticals | Series D | 0 |
2/2009 | GenoLogics | Series C | 5M |
8/2007 | Morega Systems | Series A | 10M |
2/2005 | GenoLogics | Series A | 5M |
10/2005 | CELLFOR | Series C | 32M |
10/2006 | CELLFOR | Venture Round | 5.6M |
2/2003 | Twinstrand Therapeutics | Venture Round | 6.7M |
2/2007 | Virtual Expert Clinics | Series C | 1.3M |
5/2002 | Angstrom Power | Venture Round | 0 |
8/2007 | SWITCH Materials | Venture Round | 3.1M |
10/2012 | D-Wave Systems | Venture Round | 0 |
6/2008 | sutus | Venture Round | 5M |
5/2006 | Targeted Growth | Series D | 10M |
5/2011 | General Fusion | Series B | 0 |
7/2007 | Protiva Biotherapeutics | Venture Round | 3.3M |
5/2009 | Covarity | Venture Round | 3M |
1/2006 | BTI Systems | Series C | 16.4M |
8/2009 | General Fusion | Series A | 13.8M |
12/2004 | Inimex Pharmaceuticals | Series A | 0 |
9/2010 | Covarity | Venture Round | 0 |
5/2007 | SiGe Semiconductor | Venture Round | 0 |
7/2010 | Morega Systems | Series B | 0 |
2/2007 | Covarity | Venture Round | 2.5M |
4/2005 | Datawire Communication Networks | Series B | 1.1M |
1/2014 | BTI Systems | Series D | 0 |
11/2005 | Adnavance Technologies | Series A | 3.9M |
11/2006 | Aegera Therapeutics | Series C | 12.2M |
1/2006 | Spotwave Wireless | Venture Round | 10M |
5/2006 | Covarity | Series B | 0 |
8/2014 | Verold (zyenti) | Series A | 0 |
1/2014 | ResponseTek | Venture Round | 0 |
9/2007 | BTI Systems | Series D | 0 |
1/2009 | xkoto | Series C | 3M |
7/2013 | INETCO Systems Limited | Venture Round | 0 |
8/2007 | Celator Pharmaceuticals | Series C | 10M |
5/2006 | Zeugma Systems | Series A | 15.8M |
3/2009 | Zeugma Systems | Series C | 8.8M |
1/2000 | Chrysalis ITS | Venture Round | 0 |
10/2006 | Action Pharma | Series A | 6M |
12/2014 | BuildDirect | Series C | 0 |
11/2003 | Neuromed Pharmaceuticals | Series C | 32M |
8/2007 | Neuromed Pharmaceuticals | Series E | 0 |
1/2006 | Mixpo | Series A | 6.5M |
1/2006 | CHiL Semiconductor | Seed Round | 787k |
12/2005 | ascentify | Venture Round | 539k |
4/2007 | EQO | Series B | 9M |
8/2007 | Paymentus | Venture Round | 3.6M |
2/2006 | Virtual Expert Clinics | Venture Round | 1.3M |
3/2001 | SiberCore Technologies | Series C | 0 |
5/2008 | BumpTop | Seed Round | 1.6M |
1/2011 | ClearRisk | Venture Round | 1M |
2/2006 | Marqui | Series B | 7.5M |
4/2011 | Lymbix | Venture Round | 1.4M |
2/2012 | Global Ad Source | Venture Round | 542k |
5/2013 | ClearRisk | Venture Round | 500k |
3/2021 | ClearRisk | Venture Round | 0 |
2/2009 | Layer 7 Technologies | Venture Round | 11M |
4/2007 | Octopz | Venture Round | - |
3/2009 | OneChip Photonics | Series A | 19.5M |
7/2006 | Protiva Biotherapeutics | Series C | 5M |
1/2004 | Targeted Growth | Venture Round | 2.6M |
5/2015 | General Fusion | Venture Round | 0 |
6/2007 | Distil Interactive | Series A | 2.2M |
11/2004 | Whitehill Technologies | Series B | 3.4M |
2/2008 | Adnavance Technologies | Series B | 3.8M |
2/2007 | Targeted Growth | Series D | 0 |
2/2010 | Redlen Technologies | Venture Round | 7.8M |
1/2010 | Sampling Technologies | Venture Round | 2M |
10/2006 | Distil Interactive | Seed Round | 628k |
1/2010 | SWITCH Materials | Series B | 0 |
6/2015 | SWITCH Materials | Series C | 0 |
11/2007 | CELLFOR | Venture Round | 24.5M |
5/2011 | Perspecsys | Series A | 8M |
6/2011 | Hy-Power Nano | Seed Round | 3M |
2/2009 | Mixpo | Series B | 4M |
11/2005 | xkoto | Seed Round | 535k |
10/2010 | Boreal Genomics | Series B | 6.5M |
4/2000 | Chancery Software | Venture Round | 0 |
12/2008 | Bootup Labs | Seed Round | 285.9k |
1/2006 | EQO | Series A | 3.5M |
1/2016 | HIGHLINEvc | Pre Seed Round | - |
3/2014 | Cooledge Lighting | Venture Round | 0 |
3/2021 | ClearRisk | Venture Round | 0 |
1/2016 | HIGHLINEvc | Pre Seed Round | - |
6/2015 | SWITCH Materials | Series C | 0 |
5/2015 | General Fusion | Venture Round | 0 |
12/2014 | BuildDirect | Series C | 0 |
8/2014 | Verold (zyenti) | Series A | 0 |
3/2014 | Cooledge Lighting | Venture Round | 0 |
1/2014 | ResponseTek | Venture Round | 0 |
1/2014 | BTI Systems | Series D | 0 |
7/2013 | INETCO Systems Limited | Venture Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|